<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Travelers' diarrhea: Epidemiology, microbiology, clinical manifestations, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Travelers' diarrhea: Epidemiology, microbiology, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Travelers' diarrhea: Epidemiology, microbiology, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Regina LaRocque, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jason B Harris, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Travelers' diarrhea refers to development of unformed stools among individuals from a resource-rich setting during or within 10 days of returning from travel to a resource-limited setting. Travelers' diarrhea is typically self-diagnosed. </p><p>For epidemiologic purposes, travelers' diarrhea may be defined as passage of three or more unformed stools in a 24-hour period, accompanied by at least one of these other symptoms: nausea, vomiting, abdominal pain or cramps, fever, or blood in the stool. </p><p>Episodes of travelers' diarrhea are nearly always benign and self-limited, but dehydration may be severe and pose a greater health hazard than the illness itself. Nevertheless, travelers can be educated to manage a diarrheal episode without compromising their trip or their health.</p><p>The epidemiology, microbiology, clinical manifestations, and diagnosis of travelers' diarrhea are discussed here. The treatment and prevention of travelers' diarrhea are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/99648.html" rel="external">"Travelers' diarrhea: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H2176845537"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H3114616888"><span class="h2">Frequency</span><span class="headingEndMark"> — </span>Travelers' diarrhea is the most common illness among individuals traveling from resource-rich to resource-limited regions of the world. The attack rate for travelers' diarrhea ranges between 10 and 70 percent; estimates vary greatly between studies [<a href="#rid1">1-5</a>]. </p><p>In one study including 390 travelers from the Netherlands to subtropical and tropical regions, 41 percent reported travelers' diarrhea (defined as three or more unformed stools within a 24-hour period) on post-travel questionnaires [<a href="#rid5">5</a>]. Of those, 86 percent reported watery stools, 77 percent reported abdominal discomfort or cramps, 71 percent reported fecal urgency, 20 percent reported vomiting, and only 11 percent had fever. Most had three to five stools per day; 3 percent had &gt;10 stools per day. </p><p class="headingAnchor" id="H2238207079"><span class="h2">Travel risk factors</span><span class="headingEndMark"> — </span>The organisms that cause travelers' diarrhea are most often transmitted by food and water; therefore, the risk of travelers' diarrhea is the highest in regions where sanitation and hygienic practices are poor and there is limited access to safe drinking water. Also, settings with inadequate electricity resulting in poor refrigeration can result in unsafe food storage and increased risk for disease. </p><p>The risk of travelers' diarrhea varies considerably based on destination [<a href="#rid6">6</a>]. Southeast Asia is commonly identified as the region with the highest incidence rate [<a href="#rid6">6</a>]. The risk of travelers' disease also varies by season; the risk is higher during warmer and wetter seasons [<a href="#rid7">7-9</a>].</p><p>The risk of travelers' diarrhea is highest during the first month of travel, then decreases with time [<a href="#rid6">6</a>]. Activities associated with development of travelers' diarrhea include buying food from street vendors, traveling to visit friends and relatives, and staying in "all-inclusive" lodging [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/3898.html" rel="external">"Travel advice", section on 'Food and water'</a>.)</p><p class="headingAnchor" id="H3110691662"><span class="h2">Host risk factors</span><span class="headingEndMark"> — </span>The likelihood of developing diarrheal illness correlates with the number of live organisms that reach the intestine. Any factor that enhances the ability of bacteria to survive ingestion and transit to the intestine may increase the risk for the development of diarrheal disease. As an example, individuals taking histamine blockers for ulcer disease or gastrointestinal reflux disease are at increased risk for travelers’ diarrhea, since the reduction of gastric acid enables more pathogens to enter the small bowel. Similarly, individuals with altered upper gastrointestinal anatomy or motility may be at increased risk for travelers’ diarrhea. </p><p>Travelers from higher risk regions are less likely to develop travelers' diarrhea when they travel to other high-risk regions, suggesting some degree of protective immunity from prior exposure. In addition, some genetic factors may be associated with an increased risk of travelers' diarrhea [<a href="#rid11">11</a>]. </p><p class="headingAnchor" id="H388779029"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Travelers' diarrhea may be caused by a variety of organisms; these include bacteria, viruses, and parasites  (<a class="graphic graphic_table graphicRef62537" href="/z/d/graphic/62537.html" rel="external">table 1</a>). Identifying a microbial etiology is not necessary for most cases of travelers' diarrhea but this may be warranted in certain circumstances. (See <a class="local">'Clinical approach'</a> below.)</p><p>Bacterial pathogens are the most frequent cause in patients with acute illness. In a systematic review of publications between 1990 and 2015, 62 percent of tested cases of travelers' diarrhea were due to bacterial pathogens [<a href="#rid6">6,12</a>]. </p><p>Spices in food and changes in climate do <strong>not</strong> cause travelers' diarrhea; however, variations in diet, temperature, or even time zones can alter the way a traveler feels, and the stresses of travel may exacerbate diarrheal symptoms.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacteria</strong> – Enterotoxigenic <em>Escherichia coli</em> (ETEC), enteroaggregative <em>E. coli</em>, and <em>Campylobacter</em> predominate as the bacterial causes of travelers' diarrhea [<a href="#rid6">6,13-16</a>]. <em>Shigella</em> spp, <em>Salmonella</em> spp, <em>Vibrio</em> spp, <em>Aeromonas hydrophila,</em> enteropathogenic <em>E. coli</em>, enterohemorrhagic <em>E. coli</em>, and <em>Plesiomonas</em> are less commonly identified [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/2720.html" rel="external">"Pathogenic Escherichia coli associated with diarrhea"</a>.)</p><p></p><p class="bulletIndent1">There is geographic variation to the microbial distribution of travelers' diarrhea. In Southeast Asia, <em>Campylobacter</em> species are the most common cause of travelers' diarrhea, whereas ETEC is the predominant pathogen in travelers to Latin America/Caribbean, Africa, and the Middle East [<a href="#rid6">6,16,17</a>]. </p><p></p><p class="bulletIndent1">Additional causes of microbial food-borne illness are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1">Occasionally, travelers taking malaria prophylaxis or other antibiotics develop antibiotic-associated diarrhea due to <em>Clostridioides difficile</em> [<a href="#rid18">18</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viruses</strong> – Norovirus has increasingly been identified as a cause of traveler's diarrhea with broader availability of molecular diagnostic techniques [<a href="#rid19">19,20</a>]. One review of the etiology of diarrhea among United States military personnel found norovirus to be the most commonly detected pathogen (24 percent of cases), followed by ETEC (16 percent), and <em>Campylobacter jejuni</em> (14 percent) [<a href="#rid21">21</a>]. However, prolonged shedding of norovirus can complicate interpretation of diagnostic tests. </p><p></p><p class="bulletIndent1">Rotaviruses have also been identified as a common viral pathogen [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/2681.html" rel="external">"Clinical manifestations and diagnosis of rotavirus infection"</a> and  <a class="medical medical_review" href="/z/d/html/2710.html" rel="external">"Norovirus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parasites</strong> – Most travelers are not exposed to environments with significant risk for parasite infection [<a href="#rid22">22-24</a>]. </p><p></p><p class="bulletIndent1">Regions with risk for parasitic infection among travelers include Nepal (where both <em>Giardia lamblia</em> and <em>Cyclospora cayetanensis</em> are common) and St. Petersburg (where <em>G. lamblia</em> remains hyperendemic). The mountainous regions of the West and Northeast United States are also highly endemic for <em>G. lamblia.</em> In these settings, environmental factors (such as the juxtaposition of the water supply with the habitat of certain animal species) may predispose to parasite infection.</p><p></p><p class="bulletIndent1">Uncommonly, other parasitic infections implicated in travelers’ diarrhea include <em>Cryptosporidium parvum</em>, microsporidia, and <em>Cytoisospora belli</em> [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><em>Entamoeba histolytica</em> can produce intestinal infection; it is not a common pathogen in travelers' diarrhea but can be associated with persistent diarrhea. (See  <a class="medical medical_review" href="/z/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p></p><p class="bulletIndent1"><em>Blastocystis</em> spp are protozoan parasites found in the human gastrointestinal tract; there is controversy regarding whether <em>Blastocystis</em> spp represent a commensal organism, a marker of intestinal dysbiosis, or a true pathogen. This is discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/5672.html" rel="external">"Blastocystis species"</a>.)</p><p></p><p class="headingAnchor" id="H3908165835"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H1453135112"><span class="h2">Typical signs and symptoms</span><span class="headingEndMark"> — </span>Travelers' diarrhea refers to diarrheal illness that develops among individuals from resource-rich settings during or within 10 days of returning from travel to resource-limited regions. </p><p>For epidemiologic purposes, travelers' diarrhea may be defined as passage of three or more unformed stools in a 24-hour period, accompanied by at least one of the following: nausea, vomiting, abdominal pain or cramps, fever, or blood in the stool. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong> – Most episodes of travelers' diarrhea occur between 4 and 14 days after arrival [<a href="#rid14">14</a>], but travelers' diarrhea can occur within a shorter time frame if the concentration of bacteria ingested is sufficiently high. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manifestations</strong> – The symptoms of travelers' diarrhea may vary depending on the microbial etiology. </p><p></p><p class="bulletIndent1">The classic "turista" due to enterotoxigen<em>ic E. coli</em> (ETEC) generally produces malaise, anorexia, and abdominal cramps followed by sudden onset of watery diarrhea. Very frequent stools are uncommon. Nausea and vomiting also may occur. Symptoms of colitis (such as blood or pus in the stool) are rare. Patients may develop a low-grade fever. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Categorizing severity</strong> – The severity of travelers' diarrhea can be categorized according to a classification scheme suggested by an expert panel of the International Society of Travel Medicine, which uses functional impact to define severity [<a href="#rid26">26</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mild – Diarrhea that is tolerable, is not distressing, and does not interfere with planned activities.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moderate – Diarrhea that is distressing or interferes with planned activities.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe – Diarrhea that is incapacitating or completely prevents planned activities; dysentery (passage of grossly bloody stools) is considered severe.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duration of illness</strong> – Travelers' diarrhea is generally self-limited; symptoms usually last for approximately one to five days. It is common to be unable to proceed with planned activities. In one series including more than 30,000 travelers to Jamaica (travelers’ diarrhea attack rate 24 percent), incapacity was reported for a mean of 11.6 hours from illness onset [<a href="#rid14">14</a>]. </p><p></p><p class="bulletIndent1">Patients experience symptoms for more than one week in 8 to 15 percent of cases, and as many as 2 percent of patients experience symptoms for more than one month [<a href="#rid27">27</a>].</p><p></p><p class="headingAnchor" id="H1270821611"><span class="h2">Manifestations associated with specific etiologies</span><span class="headingEndMark"> — </span>The initial symptoms are generally similar to those seen with ETEC, even when other bacterial agents such as <em>C. jejuni</em> and <em>Shigella</em> spp are implicated. However, infections with these organisms may progress to include symptoms of colitis, such as fever, tenesmus, urgency, cramping, and bloody diarrhea. (See  <a class="medical medical_review" href="/z/d/html/2715.html" rel="external">"Campylobacter infection: Clinical manifestations, diagnosis, and treatment"</a> and  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>Upper gastrointestinal symptoms (bloating, gas, nausea) are typical of giardiasis, while profuse watery diarrhea is characteristic of cholera, cryptosporidiosis, and <em>C. cayetanensis</em> infection. Symptoms of microsporidiosis may be more subtle, with bloating and intermittent diarrhea. (See  <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5733.html" rel="external">"Cryptosporidiosis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5731.html" rel="external">"Microsporidiosis"</a> and  <a class="medical medical_review" href="/z/d/html/5724.html" rel="external">"Cyclospora infection"</a>.)</p><p class="headingAnchor" id="H721722117"><span class="h2">Long-term sequelae</span><span class="headingEndMark"> — </span>Subsequent development of chronic gastrointestinal symptoms, and in particular irritable bowel syndrome, has been reported in a sizable minority of patients following travelers' diarrhea. Postinfectious irritable bowel syndrome is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2629.html" rel="external">"Pathophysiology of irritable bowel syndrome", section on 'Postinfectious'</a>.)</p><p class="headingAnchor" id="H1421148198"><span class="h1">DIAGNOSIS AND EVALUATION</span></p><p class="headingAnchor" id="H2312744829"><span class="h2">Clinical approach</span><span class="headingEndMark"> — </span>The diagnosis of travelers' diarrhea is established in an individual who develops unformed stools during or within 10 days after returning from travel to a resource-limited setting. Travelers' diarrhea is typically self-diagnosed. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>For patients who present with uncomplicated travelers' diarrhea after returning home, determination of the microbiologic agent is generally unnecessary [<a href="#rid28">28</a>]. Management of travelers' diarrhea is often symptomatic and should be initiated without regard to the specific offending agent. (See  <a class="medical medical_review" href="/z/d/html/99648.html" rel="external">"Travelers' diarrhea: Treatment and prevention"</a>.)</p><p>Circumstances in which we favor pursuing microbiologic workup include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms of colitis</strong> (bloody or mucoid stools, abdominal cramping) – In such cases, a stool culture should be performed (to evaluate for <em>Campylobacter</em>, <em>Shigella</em> spp, pathogenic <em>E. coli</em>, and <em>Salmonella</em> spp including <em>Salmonella </em>Typhi). Stool should also be sent for additional studies including Shiga toxin and <em>C. difficile</em>. In addition, blood cultures should be obtained. (See  <a class="medical medical_review" href="/z/d/html/2715.html" rel="external">"Campylobacter infection: Clinical manifestations, diagnosis, and treatment", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/2720.html" rel="external">"Pathogenic Escherichia coli associated with diarrhea"</a> and  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment"</a> and  <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">"<i>Clostridioides difficile </i>infection in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presence of fever</strong> – In such cases, blood and stool cultures should be obtained to evaluate for <em>Salmonella</em> species, including <em>S. </em>Typhi. (See  <a class="medical medical_review" href="/z/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a> and  <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presence of predominantly upper gastrointestinal symptoms</strong> (eg, bloating, gas, nausea) – In such cases, diagnostic testing for <em>G. lamblia,</em> <em>Cyclospora,</em> and <em>Cystoisospora</em> should be undertaken. Diagnostic tools include stool antigen tests, nucleic acid detection, and stool examination. (See  <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/5724.html" rel="external">"Cyclospora infection", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recent antibiotic use</strong> – For patients with antibiotic use in the preceding 8 to 12 weeks, testing for <em>C. difficile</em> diarrhea is warranted. (See  <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">"<i>Clostridioides difficile </i>infection in adults: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Persistent diarrhea</strong> – For patients with persistent diarrhea beyond 10 to 14 days, further workup may be warranted, including testing for intestinal parasitic infections [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/99648.html" rel="external">"Travelers' diarrhea: Treatment and prevention", section on 'Patients with persistent diarrhea'</a>.)</p><p></p><p class="headingAnchor" id="H2116558214"><span class="h2">Diagnostic tools</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stool culture</strong> – Stool cultures are warranted in the circumstances outlined above (see <a class="local">'Clinical approach'</a> above). Routine stool cultures are rarely informative, since enterotoxigenic <em>E. coli</em>, enteroaggregative <em>E. coli</em>, and enteropathogenic <em>E. coli</em> cannot be distinguished from nonpathogenic <em>E. coli</em>; in addition, stool culture cannot identify viral or parasitic agents. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multiplex molecular testing</strong> – Culture-independent diagnostic methods, such as multiplex polymerase chain reaction tests, are increasingly available yet expensive [<a href="#rid6">6</a>]. Multiplex molecular testing is useful for providing rapid results and may allow detection of viral infections such as norovirus, avoiding unnecessary antibiotics [<a href="#rid29">29</a>]. In addition, for chronic diarrhea due to protozoa, molecular testing can be very helpful [<a href="#rid30">30</a>]. </p><p></p><p class="bulletIndent1">Clinical interpretation of molecular test results can be complex, since multiple pathogens may be detected. As an example, in one study including more than 100 patients with travelers' diarrhea, use of a multiplex molecular panel identified multiple pathogens in 76 percent of cases; in contrast, use of conventional stool culture identified a pathogen in 24 percent of cases [<a href="#rid31">31</a>]. </p><p></p><p class="headingAnchor" id="H2770183587"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of travelers’ diarrhea includes:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic infections</strong> – Systemic infections that may include diarrhea among the clinical manifestations include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Malaria</strong> – Malaria is characterized by fever, malaise, nausea, vomiting, abdominal pain, diarrhea, myalgia, and anemia. The diagnosis of malaria is established by rapid antigen test on blood or by visualization of parasites on peripheral smear. (See  <a class="medical medical_review" href="/z/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dengue fever</strong> – Manifestations of dengue include fever, hemorrhagic manifestations, and thrombocytopenia, and occasionally diarrhea. The virus is transmitted by <em>Aedes aegypti</em> mosquitoes, which have broad epidemiologic distribution; the incubation period is four to seven days (range 3 to 10 days). The diagnosis is established via polymerase chain reaction of blood or serologic testing. (See  <a class="medical medical_review" href="/z/d/html/3025.html" rel="external">"Dengue virus infection: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19</strong> – Patients with coronavirus disease 2019 (COVID-19) may present with gastrointestinal manifestations [<a href="#rid32">32</a>]. The diagnosis of COVID-19 is established via nucleic acid amplification testing or antigen testing on respiratory tract samples. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food poisoning syndromes</strong> – Noninfectious food poisoning syndromes include shellfish or mushroom poisoning. These other syndromes can be differentiated from travelers' diarrhea by distinguishing clinical features and/or specific diagnostic testing. (See  <a class="medical medical_review" href="/z/d/html/2745.html" rel="external">"Overview of shellfish, pufferfish, and other marine toxin poisoning", section on 'Diarrheic shellfish poisoning'</a> and  <a class="medical medical_review" href="/z/d/html/16135.html" rel="external">"Clinical manifestations and evaluation of mushroom poisoning", section on 'Acute gastroenteritis'</a>.)</p><p></p><p class="bulletIndent1">Infectious food poisoning syndromes, such as those caused by <em>Staphylococcus aureus</em> and <em>Bacillus cereus</em>, may present with acute gastroenteritis symptoms. These conditions usually present with vomiting as the predominant symptom; diarrhea occurs in a minority of patients. (See  <a class="medical medical_review" href="/z/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications</strong> – New medications may be a cause of acute diarrhea in travelers; comparing the timing of drug initiation with onset of diarrhea can help evaluate for this noninfectious etiology of diarrhea.</p><p></p><p class="headingAnchor" id="H2217308745"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115404.html" rel="external">"Society guideline links: Travel medicine"</a>.)</p><p class="headingAnchor" id="H31"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/7960.html" rel="external">"Patient education: General travel advice (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/7959.html" rel="external">"Patient education: Foodborne illness (food poisoning) (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/3995.html" rel="external">"Patient education: Giardia (Beyond the Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/83761.html" rel="external">"Patient education: Travelers' diarrhea (The Basics)"</a>) </p><p></p><p class="headingAnchor" id="H682385221"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Travelers' diarrhea refers to development of unformed stools among individuals from a resource-rich setting during or within 10 days of returning from travel to a resource-limited setting. Travelers' diarrhea is typically self-diagnosed. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Travelers' diarrhea is the most common illness among individuals traveling from resource-rich to resource-limited regions of the world. The attack rate ranges between 10 and 70 percent. Organisms causing travelers’ diarrhea are transmitted via contaminated food and water. The risk is the highest in regions where sanitation and hygienic practices are poor. Risk factors include buying food from street vendors, traveling to visit friends and relatives, and staying in "all-inclusive" lodging. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – Travelers' diarrhea may be caused by a variety of organisms, including bacteria, viruses, or parasites  (<a class="graphic graphic_table graphicRef62537" href="/z/d/graphic/62537.html" rel="external">table 1</a>). Bacterial pathogens are the most frequent cause in patients with acute illness. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Most episodes of travelers' diarrhea occur between 4 and 14 days after arrival. The classic "turista" due to enterotoxigen<em>ic Escherichia coli</em> generally produces malaise, anorexia, and abdominal cramps followed by sudden onset of watery diarrhea. Very frequent stools are uncommon. Nausea and vomiting also may occur. Symptoms of colitis (such as blood or pus in the stool) are rare. Patients may develop a low-grade fever. Symptoms usually last for one to five days. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Identifying a microbial etiology is not necessary for most cases of travelers' diarrhea. We pursue microbiologic workup for patients with symptoms of colitis (bloody or mucoid stools, abdominal cramping), fever, predominantly upper gastrointestinal symptoms (bloating, gas, nausea), recent antibiotic use, and persistent diarrhea beyond 10 to 14 days. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic tools</strong> – Diagnostic tools include stool culture and molecular testing. Multiplex molecular testing is increasingly available yet expensive. This tool is useful for providing rapid results and may allow detection of viral infections, avoiding unnecessary antibiotics. Clinical interpretation of the results can be complex, since multiple pathogens may be detected. (See <a class="local">'Diagnostic tools'</a> above.)</p><p></p><p class="headingAnchor" id="H474414449"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Christine A Wanke, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lόpez-Vélez R, Lebens M, Bundy L, et al. Bacterial travellers' diarrhoea: A narrative review of literature published over the past 10 years. Travel Med Infect Dis 2022; 47:102293.</a></li><li><a class="nounderline abstract_t">Stoney RJ, Han PV, Barnett ED, et al. Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers. Am J Trop Med Hyg 2017; 96:1388.</a></li><li><a class="nounderline abstract_t">Schlagenhauf P, Weld L, Goorhuis A, et al. Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation. Lancet Infect Dis 2015; 15:55.</a></li><li><a class="nounderline abstract_t">Greenwood Z, Black J, Weld L, et al. Gastrointestinal infection among international travelers globally. J Travel Med 2008; 15:221.</a></li><li><a class="nounderline abstract_t">Soonawala D, Vlot JA, Visser LG. Inconvenience due to travelers' diarrhea: a prospective follow-up study. BMC Infect Dis 2011; 11:322.</a></li><li><a class="nounderline abstract_t">Olson S, Hall A, Riddle MS, Porter CK. Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference? Trop Dis Travel Med Vaccines 2019; 5:1.</a></li><li><a class="nounderline abstract_t">Mattila L, Siitonen A, Kyrönseppä H, et al. Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis 1992; 165:385.</a></li><li><a class="nounderline abstract_t">Mattila L, Peltola H, Siitonen A, et al. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis 1993; 17:779.</a></li><li><a class="nounderline abstract_t">Pender MA, Smith T, Brintz BJ, et al. Weather variables as important clinical predictors of bacterial diarrhoea among international travellers. J Travel Med 2022; 29.</a></li><li><a class="nounderline abstract_t">Hill DR, Beeching NJ. Travelers' diarrhea. Curr Opin Infect Dis 2010; 23:481.</a></li><li><a class="nounderline abstract_t">Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA 2015; 313:71.</a></li><li><a class="nounderline abstract_t">Lääveri T, Antikainen J, Pakkanen SH, et al. Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited. Clin Microbiol Infect 2016; 22:535.</a></li><li><a class="nounderline abstract_t">von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000; 356:133.</a></li><li><a class="nounderline abstract_t">Steffen R, Collard F, Tornieporth N, et al. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA 1999; 281:811.</a></li><li><a class="nounderline abstract_t">Adachi JA, Jiang ZD, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 2001; 32:1706.</a></li><li><a class="nounderline abstract_t">Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009; 80:609.</a></li><li><a class="nounderline abstract_t">Steffen R. Epidemiology of travellers' diarrhea. J Travel Med 2017; 24:S2.</a></li><li><a class="nounderline abstract_t">Golledge CL, Riley TV. Clostridium difficile-associated diarrhoea after doxycycline malaria prophylaxis. Lancet 1995; 345:1377.</a></li><li><a class="nounderline abstract_t">Koo HL, Ajami NJ, Jiang ZD, et al. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol 2010; 48:1673.</a></li><li><a class="nounderline abstract_t">Apelt N, Hartberger C, Campe H, Löscher T. The Prevalence of Norovirus in returning international travelers with diarrhea. BMC Infect Dis 2010; 10:131.</a></li><li><a class="nounderline abstract_t">Ashbaugh HR, Early JM, Johnson ME, et al. A prospective observational study describing severity of acquired diarrhea among U.S. military and Western travelers participating in the Global Travelers' Diarrhea Study. Travel Med Infect Dis 2021; 43:102139.</a></li><li><a class="nounderline abstract_t">Black RE. Pathogens that cause travelers' diarrhea in Latin America and Africa. Rev Infect Dis 1986; 8 Suppl 2:S131.</a></li><li><a class="nounderline abstract_t">Soave R, Ma P. Cryptosporidiosis. Traveler's diarrhea in two families. Arch Intern Med 1985; 145:70.</a></li><li><a class="nounderline abstract_t">Jokipii L, Pohjola S, Jokipii AM. Cryptosporidiosis associated with traveling and giardiasis. Gastroenterology 1985; 89:838.</a></li><li><a class="nounderline abstract_t">Goodgame R. Emerging Causes of Traveler's Diarrhea: Cryptosporidium, Cyclospora, Isospora, and Microsporidia. Curr Infect Dis Rep 2003; 5:66.</a></li><li><a class="nounderline abstract_t">Maier N, Riddle MS, Gutiérrez R, et al. A disease severity scale for the evaluation of vaccine and other preventive or therapeutic interventions for travellers' diarrhoea. J Travel Med 2022; 29.</a></li><li><a class="nounderline abstract_t">Rendi-Wagner P, Kollaritsch H. Drug prophylaxis for travelers' diarrhea. Clin Infect Dis 2002; 34:628.</a></li><li><a class="nounderline abstract_t">Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:e45.</a></li><li><a class="nounderline abstract_t">Lääveri T, Antikainen J, Mero S, et al. Bacterial, viral and parasitic pathogens analysed by qPCR: Findings from a prospective study of travellers' diarrhoea. Travel Med Infect Dis 2021; 40:101957.</a></li><li><a class="nounderline abstract_t">Gefen-Halevi S, Biber A, Gazit Z, et al. Persistent abdominal symptoms in returning travellers: clinical and molecular findings. J Travel Med 2022; 29.</a></li><li><a class="nounderline abstract_t">Kutsuna S, Hayakawa K, Mezaki K, et al. Spectrum of enteropathogens in cases of traveler's diarrhea that were detected using the FilmArray GI panel: New epidemiology in Japan. J Infect Chemother 2021; 27:49.</a></li><li><a class="nounderline abstract_t">Patel AP, Sanders TK, Prakash P, et al. Gastrointestinal Manifestations of Coronavirus Disease 2019 Across the United States: A Multicenter Cohort Study. Gastro Hep Adv 2022; 1:909.</a></li></ol></div><div id="topicVersionRevision">Topic 2709 Version 41.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35247581" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Bacterial travellers' diarrhoea: A narrative review of literature published over the past 10 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28719282" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25477022" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18666921" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Gastrointestinal infection among international travelers globally.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22099542" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Inconvenience due to travelers' diarrhea: a prospective follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30675367" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1730905" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8268363" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35134202" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Weather variables as important clinical predictors of bacterial diarrhoea among international travellers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20683261" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Travelers' diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25562268" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Traveler's diarrhea: a clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26970046" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10963251" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Risk and aetiology of diarrhoea at various tourist destinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10071002" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11360211" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19346386" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Global etiology of travelers' diarrhea: systematic review from 1973 to the present.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28520996" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiology of travellers' diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7752793" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clostridium difficile-associated diarrhoea after doxycycline malaria prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20305012" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20500860" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The Prevalence of Norovirus in returning international travelers with diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34265437" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A prospective observational study describing severity of acquired diarrhea among U.S. military and Western travelers participating in the Global Travelers' Diarrhea Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3014633" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pathogens that cause travelers' diarrhea in Latin America and Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4038599" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Cryptosporidiosis. Traveler's diarrhea in two families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4029564" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cryptosporidiosis associated with traveling and giardiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12525293" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Emerging Causes of Traveler's Diarrhea: Cryptosporidium, Cyclospora, Isospora, and Microsporidia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34490456" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A disease severity scale for the evaluation of vaccine and other preventive or therapeutic interventions for travellers' diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11803509" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Drug prophylaxis for travelers' diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29053792" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33359433" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bacterial, viral and parasitic pathogens analysed by qPCR: Findings from a prospective study of travellers' diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35134178" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Persistent abdominal symptoms in returning travellers: clinical and molecular findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32839110" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Spectrum of enteropathogens in cases of traveler's diarrhea that were detected using the FilmArray GI panel: New epidemiology in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35874930" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Gastrointestinal Manifestations of Coronavirus Disease 2019 Across the United States: A Multicenter Cohort Study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
